T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: Effects of cyclosporine and donor antigen

Transplantation

Volumn 63, Issue 8, 1997, Pages 1053-1058

  Chandraker, Anil ^a   Russell, Mary E ^a   Glysing Jensen, Troels ^a   Willett, Theresa A ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; GRAFT OCCLUSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

EID: 0030890270     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00002     Document Type: Article

References (42)

1. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191.
2. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555.
3. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 1995; 81: 979.
4. Sayegh MH, Turka LA. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol 1995; 6: 1143.
5. Lenschow DJ, Zeng Y, Thistlethwaite R, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
6. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
7. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
8. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
9. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
10. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
11. Hancock WW, Sayegh MH, Peach R, Linsley PS, Turka LA. Costimulatory function of CD40L, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
12. Larsen CP, Alwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
13. Tilney NL, Whitley WD, Diamond JR, Kupiec WJ, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1991; 52: 389.
14. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and kidney: have rational treatment options emerged? Transplantation 1992; 53: 1169.
15. Paul L. Chronic renal transplant loss. Kidney Int 1995; 47: 1491.
16. Hostetter TH. Chronic transplant rejection. Kidney Int 1994; 46: 266.
17. Carpenter CB. Long-term failure of renal transplants: adding insult to injury. Kidney Int 1995; 48: S40.
18. Adams DH, Russell WW, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunol Rev 1993; 134: 7.
19. Russell ME, Fujita M, Masek MA, Rowan RA, Billingham ME. Cardiac graft vascular disease: nonselective involvement of large and small vessels. Transplantation 1993; 56: 1115.
20. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
21. Russell ME, Adams DH, Wyner LR, Yamashita Y, Halnon NJ, Karnovsky MJ. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci USA 1993; 90: 6086.
22. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59: 572.
23. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97: 833.
24. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T cell costimulation prevents development of experimental chronic allograft rejection. Proc Natl Acad Sci USA 1996; 93: 12439.
25. Koskinen PK, Lemström KB, Häyry PJ. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol 1995; 146: 972.
26. Bolling SF, Lin H, Wei R-Q, Linsley P, Turka LA. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J Surg Res 1994; 57: 60.
27. Perico N, Imberti O, Bontelpelli M, Remuzzi G. Toward novel antirejection strategies: in vivo suppressive properties of CTLA4Ig. Kidney Int 1995; 47: 241.
28. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445.
29. + T cells unless costimulation is prevented. Transplantation 1995; 60: 734.
30. Radvanyi LG, Shi Y, Vaziri H, et al. CD28 costimulation inhibits TCR-induced apoptosis during primary T cell responses. J Immunol 1996; 156: 1788.
31. Labalette M, Queyrel V, Masy E, Pruvot F, Dessaint J. Implication of cyclosporine in the up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients. Transplantation 1995; 59: 1714.
32. Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ. Intrathymic tolerance in the Lewis to F344 chronic cardiac allograft rejection model. Transplantation 1995; 59: 1647.
33. Orloff MS, DeMara EM, Coppage ML, et al. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation 1995; 59: 282.
34. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat: donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995; 60: 971.
35. Murase NM, Starzl TE, Tanable M, et al. Variable chimerism, graft versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995; 60: 158.
36. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405.
37. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541.
38. Pearson T, Alexander D, Hendrix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model: evidence for hematopoietic chimerism. Transplantation 1995; 61: 997.
39. Davies CB, Madden RL, Alexander JW, Cofer BR, Fisher RA, Anderson P. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival. Transplantation 1993; 55: 1107.
40. Salom R, Maguire J, Hancock W. Mechanisms of a clinically relevant protocol to induce cardiac allografts: perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production. Transplantation 1993; 56: 1309.
41. Ahmed SM, Baslaim G, Esherlby D, Guttman RD, Tchervenkov JI. The effect of transfusion with donor-specific peripheral lymphocytes, whole blood, or erythrocytes on cardiac allograft survival in cyclosporine-treated rats. Transplantation 1994; 57: 634.
42. Reinsmoen NL, Jackson A, McSherry C, et al. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation 1995; 60: 1546.